ATC Group: M01AG01 Mefenamic acid

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M01AG01 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M01 Antiinflammatory and antirheumatic products
3 M01A Antiinflammatory and antirheumatic products, non-steroids
4 M01AG Fenamates
5 M01AG01 Mefenamic acid

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
ORAL Oral 1 g

Active ingredients in M01AG01

Active Ingredient

Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties.

Related product monographs

Document Type Information Source  
 ALFOXAN Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 ALFOXAN Hard capsule MPI, EU: SmPC Υπουργείο Υγείας (CY)
 PONSTAN FORTE Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 PONSTEL Capsule / Tablet / Suspension MPI, Generic Health Products Regulatory Authority (ZA)

Medicines in this ATC group

Australia (AU)

Austria (AT)

Brazil (BR)

Cyprus (CY)

France (FR)

Ireland (IE)

Japan (JP)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.